Diabetes/Endocrinology

General Medicine

HIV/Infectious Diseases

Pulmonary Medicine

Novel drug for mobilising stem cells for transplantation in multiple myeloma

Miriam Davis | Clinical Summary | 17 April 2023

92.5% of recipients met the primary outcome compared with 26% with standard treatment.

Background

Multiple myeloma patients’ survival is improved by autologous haematopoietic stem cell transplantation (ASCT).
ASCT first consists of collecting from the patient an optimal number of healthy haematopoietic stem and progenitor cells (HSPCs) expressing the marker CD34.
These healthy stem cells are stored and re-infused after the patient is exposed...

General Medicine

Multiple Myeloma

5 PTS expert

What is the difference in clinical outcomes between insulin glargine-300 and insulin degludec/aspart?

5 PTS expert

What are the effects of cholinesterase inhibitors on the management of psychotic symptoms in patients with Alzheimer's disease?

Quiz challenge Emerging diseases: COVID-19

Closed 10 Questions Available Ends on 1 October 2020

ESMO 2020 topic challenge

Closed 5 Questions Available Ends on 21 April 2021

Women's health challenge

Closed 10 Questions Available Ends on 12 May 2021

Antibiotics - Consequence of MDR carriage

Closed 6 Questions Available Ends on 12 May 2021

Neurological disorders challenge

Closed 10 Questions Available Ends on 12 June 2021

Rheumatology challenge

Closed 10 Questions Available Ends on 12 July 2021

Lyme Disease

Closed 11 Questions Available Ends on 12 July 2021

Mental health challenge

Closed 10 Questions Available Ends on 12 August 2021

Topic challenge - Children conditions

Closed 7 Questions Available Ends on 12 September 2021

Lyme Disease

Closed 11 Questions Available Ends on 12 September 2021